Keyphrases
Post-transplant Outcomes
100%
Atypical Hemolytic Uremic Syndrome (aHUS)
100%
Clinical Features
16%
Renal Transplant
16%
Pretransplant
16%
Graft Survival
16%
Histopathological Features
16%
University of Minnesota
8%
Immunosuppression
8%
Cyclosporine
8%
Transplantation
8%
Recurrence Risk
8%
Allograft
8%
Living Donor
8%
Renal Transplantation
8%
Graft Outcome
8%
High Incidence
8%
Donor Graft
8%
Recurrence Rate
8%
Syndrome-based
8%
Vascular Rejection
8%
Immunology and Microbiology
Transplant Procedure
100%
Immunosuppression
50%
Vascular Rejection
50%
Ciclosporin
50%
Allotransplantation
50%
Kidney Transplantation
50%
Medicine and Dentistry
Atypical Hemolytic Uremic Syndrome
100%
Recurrent Disease
33%
Kidney Graft
16%
Graft Survival
16%
Clinical Feature
8%
Allograft
8%
Immunosuppressive Treatment
8%
Kidney Transplantation
8%
Cyclosporine
8%
Recurrence Risk
8%
Vascular Rejection
8%
Pharmacology, Toxicology and Pharmaceutical Science
Hemolytic Uremic Syndrome
100%
Recurrent Disease
33%
Ciclosporin
8%
Recurrence Risk
8%
Clinical Feature
8%
Biochemistry, Genetics and Molecular Biology